Correlation Between Evertz Technologies and Lipocine

Can any of the company-specific risk be diversified away by investing in both Evertz Technologies and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evertz Technologies and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Evertz Technologies Limited and Lipocine, you can compare the effects of market volatilities on Evertz Technologies and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evertz Technologies with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evertz Technologies and Lipocine.

Diversification Opportunities for Evertz Technologies and Lipocine

-0.04

Correlation Coefficient

Evertz Technologies  Lipocine

Good diversification

The 3 months correlation between Evertz and Lipocine is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Evertz Technologies Limited and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Evertz Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evertz Technologies Limited are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Evertz Technologies i.e., Evertz Technologies and Lipocine go up and down completely randomly.

Pair Corralation between Evertz Technologies and Lipocine

Assuming the 90 days horizon Evertz Technologies Limited is expected to under-perform the Lipocine. But the pink sheet apears to be less risky and, when comparing its historical volatility, Evertz Technologies Limited is 3.47 times less risky than Lipocine. The pink sheet trades about -0.1 of its potential returns per unit of risk. The Lipocine is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  501.00  in Lipocine on September 24, 2024 and sell it today you would lose (14.00) from holding Lipocine or give up 2.79% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.0%
Values	Daily Returns

Evertz Technologies Limited  vs.  Lipocine

Evertz Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Evertz Technologies Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Evertz Technologies is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Lipocine

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental indicators, Lipocine displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Evertz Technologies and Lipocine

The main advantage of trading using opposite Evertz Technologies and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evertz Technologies position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.

The idea behind Evertz Technologies Limited and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.